A guide to PIN1 function and mutations across cancers

Maguie El Boustani, Lucia De Stefano, Isabella Caligiuri, Nayla Mouawad, Carlotta Granchi, Vincenzo Canzonieri, Tiziano Tuccinardi, Antonio Giordano, Flavio Rizzolio

Research output: Contribution to journalArticlepeer-review


PIN1 is a member of a family of peptidylprolyl isomerases that bind phosphoproteins and catalyze the rapid cis–trans isomerization of proline peptidyl bonds, resulting in an alteration of protein structure, function, and stability. PIN1 is overexpressed in human cancers, suggesting it promotes tumorigenesis, but depending on the cellular context, it also acts as a tumor suppressor. Here, we review the role of PIN1 in cancer and the regulation of PIN1 expression, and catalog the single nucleotide polymorphisms, and mutations in PIN1 gene associated with cancer. In addition, we provide a 3D model of the protein to localize the mutated residues.

Original languageEnglish
Article number1477
Number of pages10
JournalFrontiers in Pharmacology
Publication statusPublished - Jan 1 2019


  • 3D modeling
  • Cancer
  • Mutations
  • PIN1
  • SNP

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'A guide to PIN1 function and mutations across cancers'. Together they form a unique fingerprint.

Cite this